Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleCS1, a controlled‐release formulation of valproic acid, for the treatment of patients with pulmonary arterial hypertension: Rationale and design of a Phase 2 clinical trial.AuthorsBenza, Raymond L.; Adamson, Philip B.; Bhatt, Deepak L.; Frick, Fredrik; Olsson, Gunnar; Bergh, Niklas; Dahlöf, BjörnPublicationPulmonary Circulation, 2024, Vol 14, Issue 1, p1ISSN2045-8932Publication typeArticleDOI10.1002/pul2.12323